SFS
LGND icon

Sowell Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History

Sowell Financial Services’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303K Buy
1,516
+188
+14% +$37.2K 0.01% 832
2025
Q4 		$251K Buy
+1,328
New +$255K 0.01% 905
2020
Q4 		– Sell
-18
Closed -$1K – 2787
2020
Q3 		$1K Sell
18
-11
-38% -$751 ﹤0.01% 2393
2020
Q2 		$2K Sell
29
-86
-75% -$5.45K ﹤0.01% 2174
2020
Q1 		$5K Sell
115
-108
-48% -$6.12K ﹤0.01% 1821
2019
Q4 		$14K Sell
223
-5
-2% -$334 ﹤0.01% 1566
2019
Q3 		$14K Buy
+228
New +$14.3K ﹤0.01% 1412

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Sowell Financial Services's LGND Position: Q1 2026 in Review

Sowell Financial Services increased its Ligand Pharmaceuticals (LGND) stake by 14% in Q1 2026, buying an estimated $37.2K and bringing the position to 1,516 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #832.

Sowell Financial Services first reported a position in LGND in Q3 2019 and has held it in 7 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Sowell Financial Services held 1,516 shares of Ligand Pharmaceuticals worth $303K as of Q1 2026.
  • Sowell Financial Services bought 188 Ligand Pharmaceuticals shares in Q1 2026, an estimated $37.2K.
  • Ligand Pharmaceuticals made up 0.01% of Sowell Financial Services's portfolio in Q1 2026, its #832 holding.
  • Sowell Financial Services first reported a position in Ligand Pharmaceuticals in Q3 2019 and has held it in 7 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Sowell Financial Services's 13F filing for Q1 2026, filed 20 Apr 2026.